CRXM insider filings
Gene Biotherapeutics, Inc. — 2 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-04-28. Screen CRXM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CRXM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Gene Biotherapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-04-28 | 4 | Jemapete Christopher J — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2021-03-18 | 4 | Jemapete Christopher J — 10% owner | Purchase (P): 300,000 @ $0.04 · Purchase (P): 200,000 @ $0.40 | EDGAR |
Recent 8-K events — Gene Biotherapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-08-09 | 8-K/A | 4.01 — Changes in Registrant's Certifying Accountant | EDGAR |
| 2021-08-05 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant | EDGAR |
| 2021-07-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-04-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CRXM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs